Global Leader in Smart Home Robotics Offers Chewy Customers Robotic Vacuums and Mops at a Discounted Rate in Celebration of the Launch

HONG KONG, Aug. 19, 2025 /PRNewswire/ — Roborock, the #1 selling robot vacuum brand worldwide, is excited to announce that its best-selling robot vacuums and mops, designed to tackle the everyday mess of pet hair, are now available at Chewy, a trusted destination for pet parents and partners everywhere. Known for their powerful suction and intelligent navigation, Roborock’s smart home vacuums effortlessly clean up pet hair, dander, and other messes furry friends leave behind—so you don’t have to.

As part of this new availability at Chewy, Roborock will be offering exclusive deals on a curated selection of robotic and handheld vacuums, including the Q8 Max, Q10 X5, QV 35A, Qrevo Curv S5X0, and F25. Whether shopping for yourself or a loved one, give the pet parent in your life the gift of a hassle-free, spotless home.

“Roborock is thrilled to bring its ultra-intelligent, smart home cleaning solutions to Chewy’s community of loving pet parents,” said Quan Gang, President of Roborock. “We love our pets, but we know life with them can be messy and our robot vacuums are designed to take the cleanup off your plate. As the demand for hands-free cleaning increases, we’re eager to connect with the passionate Chewy community. We’re excited to see how pet parents integrate Roborock into their routines, giving them more time to enjoy with their furry companions!”

Pet parents can now explore a wide selection of Roborock’s robotic vacuums available at Chewy, including:

• Roborock Q8 Max: Equipped with Roborock’s most powerful DuoRoller™ Brush System and 5,500Pa suction power, it removes 20% more hair from carpets and prevents hair tangling. LiDAR based navigation curates a detailed map of its surroundings and Reactive Tech Obstacle Avoidance allows the robot to maneuver around common household hazards. MSRP: $599.99, Sale Price: $259.99
• Roborock F25: Leaving no spot untouched, this handheld vacuum and mop combo has a flat design allowing it to reach under furniture with a 4.92 clearance. The cordless design gives ultimate freedom, while its impressive 20,000Pa suction power effortlessly tackles wet and dry messes. MSRP: $399.99, Sale Price: $349.99
• Roborock Q10 X5 Series: Featuring 10,000Pa suction power and a JawScrapers Comb anti-tangle main brush and an anti-tangle side brush, this advanced system ensures smooth cleaning and reduced maintenance. In DEEP+ mopping mode, mopping paths are finely divided for a deep, thorough clean to tackle stubborn dirt stains. Q10 X5: MSRP: $359.99, Sale Price: $299.99; Q10 X5+: MSRP: $499,99, Sale Price: $319.99
• Roborock QV 35A (White): With 8,000Pa suction power and an all-in-one docking station, it delivers ultimate cleaning convenience. The Dual Anti-Tangle System and Reactive Tech Obstacle Avoidance ensures seamless navigation, while Dual Liftable Spinning Mops adapt to any surface. MSRP: $649.99, Sale Price: $439.99
• Roborock Qrevo Curv S5X: Where elegance meets innovation, the Dual Anti-Tangle System prevents hair clogs for effortless cleaning, while 17,000Pa suction power and the FlexiArm™ Technology ensures every corner is spotless. MSRP: $1,149.99, Sale Price: $949.99

To shop Roborock at Chewy and take advantage of these exclusive launch deals, visit www.chewy.com. For more information on Roborock and to explore additional products, please visit www.us.roborock.com.

About Roborock 

Roborock is a leading smart cleaning brand renowned for its intelligent cleaning solutions. With a steadfast dedication to becoming a global leading smart appliance player, Roborock enriches lives with its innovative line of robotic, cordless, wet/dry vacuum cleaners, and washer-dryers. Rooted in a user-centric approach, our R&D-driven solutions cater to diverse cleaning needs in over 15 million homes across 170+ countries. Headquartered in Beijing and with strategic subsidiaries in key markets, including the United States, Japan, the Netherlands, Poland, Germany, and South Korea, Roborock is dedicated to elevating its market presence worldwide. For more information, visit https://global.roborock.com/. 

Media Contact:
Marisa Lapointe
Rachel Kay Public Relations
a FINN Partners Company
925-407-6438
marissa.lapointe@finnpartners.com

PANAMA CITY, Aug. 19, 2025 /PRNewswire/ — HTX, a leading global crypto exchange, achieved standout growth during July’s market rally, with significant increase in new users, trading volume, and stunning returns on new listings. The exchange demonstrated comprehensive upgrades across products, branding, security, and services, showcasing robust growth momentum and operational excellence.

Trading Volume Growth Ranks No.1 Among Top Exchanges

According to CoinGecko’s latest Q2 exchange report, HTX topped global rankings for trading volume growth, significantly outperforming industry averages. Additionally, CoinDesk’s July exchange market share report noted that HTX achieved the second-largest market share increase year-to-date, trailing only Binance—cementing its place among the top-tier global trading platforms.

In July, HTX achieved remarkable performance metrics, including a 45% surge in new user registrations and 33% growth in trading volume month-over-month. HTX’s native growth engine keeps firing on all cylinders, propelled by surging organic traffic and industrial rankings that are fostering an increasingly vibrant ecosystem.

HTX listed 12 new assets in July spanning AI, meme coin, and layer 1 sectors. Among them, token M debuted exclusively on the platform and soared as much as 25x, creating a significant wealth effect for early participants. The AI-focused ANI, buoyed by comments from Elon Musk, quickly became the hottest on-chain project in the humanoid AI category, posting a peak gain of 426% after listing. Other additions such as BLUM and COOKIE broadened HTX’s exposure to high-growth sectors.

Campaigns Drive Liquidity and Brand Reach

On the marketing operations front, HTX ran campaigns exclusive to stablecoins, centered on USD1, USDC, and USDD, generating over $400 million in spot trading volume. Additionally, the HTX 12th-Anniversary Carnival has begun and will run until September 12. Participants can light up “Task Planets” to earn rewards, including trading fee rebate vouchers, 0% margin interest vouchers, token airdrops, merchandise, and entries into lucky draws with grand prizes of 120 million $HTX and a $2,000 travel fund.

During Istanbul Blockchain Week, HTX achieved 48+ million impressions in the Turkey market alone, and built deeper ties with partners including 0G Labs, 100xLabs, and Castrum Capital, which facilitated the listing of COOKIE. Online exposure rose by 60.8% versus prior events, with registrations and deposits hitting 14-day highs.

Research and Product Upgrades Strengthen Platform

This July, HTX Research published the first part of its in-depth report “The New Stablecoin Order: Restructuring Global Payments, Regulatory Legitimization, and the Capital War,” offering a macro view of stablecoin dynamics and forward trends.

HTX also launched version 11.0 of its app, redesigning the homepage, assets page, and trading page with overhauled interfaces. Following the upgrade, homepage click-through rates jumped by 24%, streamlining the user experience.

DAO Vision Refreshes with New Whitepaper

HTX DAO released a newly updated Whitepaper, marking a pivotal declaration of strategic direction. The initiative signals HTX’s evolution—from a centralized exchange to a core force in on-chain financial governance—committed to building a user-led “Freeport of Finance.” Under this vision, all participants will not only share in the platform’s growth but also gain genuine decision-making power. Moving forward, the development of HTX DAO will be driven collectively by its community, opening a new chapter that blends decentralized governance with CeFi infrastructure.

Strong Security and Transparent Reserves

As a pioneer in implementing Merkle Tree Proof of Reserves, HTX has consistently demonstrated its dedication to transparency by publicly disclosing reserve data for 34 consecutive months. As of August 1, 2025, all reserve ratios stood at or above 100%, with full transparency via the Assets > PoR Reports section on its website.

From accelerating user and trading growth to delivering standout crypto returns, product innovation, and global brand engagement, the July performance numbers underscore HTX’s ability to execute across multiple fronts. The exchange continues to deepen its user-centric approach and advance product and service innovations to help more traders seize the opportunities of the next market cycle.

About HTX

Founded in 2013, HTX (formerly Huobi) has evolved from a virtual asset exchange into a comprehensive ecosystem of blockchain businesses that span digital asset trading, financial derivatives, research, investments, incubation, and other businesses.

As a world-leading gateway to Web3, HTX harbors global capabilities that enable it to provide users with safe and reliable services. Adhering to the growth strategy of “Global Expansion, Thriving Ecosystem, Wealth Effect, Security & Compliance,” HTX is dedicated to providing quality services and values to virtual asset enthusiasts worldwide.

To learn more about HTX, please visit https://www.htx.com/ or HTX Square , and follow HTX on X, Telegram, and Discord.

RIGA, Latvia, Aug. 19, 2025 /PRNewswire/ — Northern European data center operator Delska’s upcoming facility, EU North Riga LV DC1, has been awarded the prestigious Uptime Institute Tier III Design Certification—an important milestone ahead of its planned launch at the end of this year. Once operational, it will be one of the greenest data centers in the Baltic region.

Delska’s new 10MW data center in Latvia achieves Tier III Design Certification

The Tier III Design certification ensures the facility meets strict standards for redundancy, safety, and uninterrupted service, guaranteeing 99.982% uptime. “In a world where even a few seconds of downtime can cost thousands, Tier III means our infrastructure stays online—even during planned maintenance,” said Delska CEO Andris Gailitis.

Addressing power shortages in major European hubs, the 10 MW site, offering up to 250 kW per rack, is built for next-generation workloads, including AI and high-performance computing (HPC). Its modular 6,000 m² layout is fully scalable, with the ability to expand the data center campus site up to 30 MW.

Sustainability is at the core of the design. The facility will run entirely on 100% wind energy, with backup generators powered by Neste MY renewable diesel. Targeting a PUE of just 1.3, it will use advanced free-cooling systems, hot-aisle containment, an effective Weiss Technik wall cooling system and Trane Turbocor-based chillers. It supports both air cooling and high-density direct-to-chip cooling. Delska also aims for LEED green building certification, an achievement held by fewer than 15 buildings in Latvia.

Upon completion, LV DC1 will undergo Tier III Facility certification to confirm its construction and operations meet the same high standard as its design. This will be Delska’s third Tier III-certified data center and sixth overall, joining two Tier III Facility-certified sites in Lithuania. Plans include an additional Lithuanian data center and another facility in the region, strengthening Delska’s Baltic data centers’ network.

About Delska

Delska is one of the largest data center operators in the Baltics, with over 26 years in IT and network infrastructure. Operating fully green Tier III and PCI-DSS certified facilities in Riga and Vilnius with 19 MW capacity, Delska also maintains points of presence in Frankfurt, Amsterdam, and Stockholm. Its portfolio includes cloud, server rental, network, security, and managed services.

Since being acquired by Quaero European Infrastructure Fund II in 2020, Delska has significantly expanded its infrastructure and improved energy efficiency. In 2024, DEAC (Latvia) and DLC (Lithuania) merged under a new Delska brand, and this year RackRay (Lithuania) joined the group of companies.

CHENGDU, China, Aug. 19, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”, HKEX: 6990) announced that clinical data from a Phase II study evaluating novel TROP2 antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) in combination with PD-L1 monoclonal antibody (mAb) tagitanlimab for the first-line treatment of advanced or metastatic non-small cell lung cancer (NSCLC) have been published in Nature Medicine (Impact Factor: 58.7).

The publication highlighted initial findings from the Phase II OptiTROP-Lung01 study, evaluating the efficacy and safety results of sac-TMT in combination with tagitanlimab as a first-line treatment of advanced or metastatic NSCLC patients without actionable genomic alterations. The study was led by Prof. Zhang Li’s team at the Center for Cancer Prevention and Control, Sun Yat-sen University, China. Patients in Cohort 1A received sac-TMT (5 mg/kg, Q3W) plus tagitanlimab (1200 mg, Q3W) in a three-week cycle, while patients in Cohort 1B were treated with sac-TMT (5 mg/kg, Q2W) plus tagitanlimab (900 mg, Q2W) in a four-week cycle. Patients received sac-TMT in combination with tagitanlimab in a non-randomized manner until disease progression or unacceptable toxicity. Median follow-ups for Cohort 1A and Cohort 1B were 19.3 months and 13.0 months, respectively (Data cutoff date: May 27, 2024).

The study results demonstrated promising anti-tumor activity, and manageable safety of sac-TMT in combination with tagitanlimab as a first-line treatment for advanced or metastatic NSCLC patients. A total of 40 patients in Cohort 1A and 63 patients in Cohort 1B were included in the full analysis set (FAS) for efficacy assessment. In Cohort 1A and Cohort 1B, respectively, the confirmed objective response rates (ORRs) were 40.0% (95% CI: 24.9–56.7) and 66.7% (95% CI: 53.7–78.0), and the ORRs were:

• 44.4% and 64.7% among patients with non-squamous carcinoma, 36.4% and 69.0% with squamous carcinoma;
• 41.7% and 57.1% among patients with PD-L1 tumor proportion score (TPS) <1%;
• 38.5% and 63.2% for TPS 1–49%;
• 40.0% and 78.3% for TPS ≥50%.

The median progression-free survival (mPFS) for Cohort 1A was 15.4 months (95% CI: 6.7–17.9) and not reached (95% CI: 9.6–NE) for Cohort 1B.

The most common grade ≥3 treatment-related adverse events (TRAEs) for both Cohorts 1A and 1B were decreased neutrophil count, decreased white blood cell count and anemia. No treatment-related deaths were observed.

Subgroup analyses showed consistent efficacy across PD-L1 and TROP2 expression levels, as well as in both squamous and non-squamous histological subtypes.

Dr. Michael Ge, CEO of Kelun-Biotech, commented: “The OptiTROP-Lung01 study supports the promising efficacy and safety of sacituzumab tirumotecan in combination with tagitanlimab as a first-line treatment for patients with advanced NSCLC. The results were observed across PD-L1/TROP2 expression levels and histological subtypes and support the advancement potential of sac-TMT from later-line to front-line therapy. The publication of results from several studies in top-tier international journals reflects the recognition of our innovation-driven development strategy. We will continue to work to address critical clinical challenges and unmet medical needs, striving to deliver more therapeutic options and improve quality of life for patients.”

About sac-TMT

Sac-TMT, a core product of the Company, is a novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as NSCLC, breast cancer (BC), gastric cancer (GC), gynecological tumors among others. Sac-TMT is developed with a novel linker to conjugate the payload, a belotecan-derivative topoisomerase I inhibitor with a drug-to-antibody-ratio (DAR) of 7.4. Sac-TMT specifically recognizes TROP2 on the surface of tumor cells by recombinant anti-TROP2 humanized monoclonal antibodies, which is then endocytosed by tumor cells and releases KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment. Given that KL610023 is membrane permeable, it can enable a bystander effect, or in other words kill adjacent tumor cells.

In May 2022, the Company licensed the exclusive rights to MSD (the tradename of Merck & Co., Inc., Rahway, NJ, USA) to develop, use, manufacture and commercialize sac-TMT in all territories outside of Greater China (includes Mainland China, Hong Kong, Macao, and Taiwan).

To date, two indications for sac-TMT have been approved and marketed in China for the treatment of adult patients with unresectable locally advanced or metastatic TNBC who have received at least two prior systemic therapies (at least one of them for advanced or metastatic setting) and EGFR mutation-positive locally advanced or metastatic non-squamous NSCLC following progression on EGFR-TKI therapy and platinum-based chemotherapy. In addition, two new indication applications for sac-TMT for the treatment of adult patients with EGFR-mutant locally advanced or metastatic NSCLC who progressed after treatment with EGFR-TKI therapy and with unresectable locally advanced, metastatic HR+/HER2- BC who have received prior endocrine therapy and other systemic treatments in the advanced or metastatic setting were accepted by the CDE, and were included in the priority review and approval process. As of today, the Company has initiated 9 registrational clinical studies in China. MSD has initiated 14 ongoing Phase III global clinical studies of sac-TMT as a monotherapy or with pembrolizumab^[1] or other agents for several types of cancer. These studies are sponsored and led by MSD.

About Tagitanlimab

Tagitanlimab is the first PD-L1 mAb globally to receive authorization for the first-line treatment of NPC. Previously, the NMPA has approved the marketing in China of tagitanlimab used in combination with cisplatin and gemcitabine for the first-line treatment of patients with R/M NPC and monotherapy for the treatment of patients with recurrent or metastatic NPC who have failed after prior 2L+ chemotherapy, respectively.

About Kelun-Biotech

Kelun-Biotech（6990.HK）is a holding subsidiary of Kelun Pharmaceutical (002422.SZ), which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. The company focuses on major disease areas such as solid tumors, autoimmune, inflammatory, and metabolic diseases, and in establishing a globalized drug development and industrialization platform to address the unmet medical needs in China and the rest of world. The Company is committed to becoming a leading global enterprise in the field of innovative drugs. At present, the Company has more than 30 ongoing key innovative drug projects, of which 3 projects have been approved for marketing, 1 project is in the NDA stage and more than 10 projects are in the clinical stage. The company has established one of the world’s leading proprietary ADC platforms, OptiDC™, and has 1 ADC project approved for marketing, 1 ADC project in NDA stage and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit https://kelun-biotech.com/.

https://doi.org/10.1038/s41591-025-03883-5

Media: klbio_pr@kelun.com 

Smart, Streamlined Checkout Experiences for the Next-Gen Guest

ORLANDO, Fla., Aug. 19, 2025 /PRNewswire/ — accesso Technology Group (AIM: ACSO), the premier technology solutions provider for attractions and venues worldwide, today announced the release of accessoPay 3.0, the latest evolution of its digital payment platform. Representing a pivotal step in accesso’s next-generation payment strategy, this release delivers a fully redesigned checkout experience: faster, smarter, and more secure; engineered to maximize conversion while meeting modern security and usability standards.

The future of payments, simplified with accessoPay 3.0.

With a streamlined interface, refined guest journey, and robust integrations with Cybersource, part of Visa Acceptance Solutions, and with Accertify, accessoPay 3.0 empowers operators to deliver seamless eCommerce transactions, enhanced fraud protection, and greater guest confidence at every digital touchpoint.

“With AccessoPay 3.0, the team has redefined the checkout experience for attractions and venues,” said Michael Wiggins, Senior Director, Global Services, accesso. “This release is focused on creating an even smoother and more intuitive guest experience, while supporting our clients’ revenue goals through fast, smart and secure payment tools.”

Key Highlights of accessoPay 3.0:

• Revamped checkout flow and UI, with intuitive progress indicators, fewer clicks, and a streamlined user journey.
• Expanded digital wallet support, including updates to:
  • Apple Pay and Google Pay, enabling fast, secure payments across supported web and mobile browsers
  • PayPal, with full support for Venmo, Pay Later, and PayPal Credit
  • Trustly, offering direct bank payments for select global markets; no card or app required
• Next-gen tokenization and payment security, including:
  • Token Management Service (TMS) by Cybersource, built on Visa’s infrastructure to securely capture and manage card data for recurring and one-click purchases
  • Network token support, boosting approval rates and reducing fraud exposure
• Integrated upselling features, including:
  • Protecht Ticket Insurance, embedded at checkout
  • Donation prompts to support charitable initiatives
  • Flex Pay (formerly Uplift) installment loans, offer guests flexible payment options
• Enhanced fraud protection with Accertify, featuring:
  • Pre- and post-authorization risk checks for real-time threat detection
  • Dynamic 3DS enablement, adapting security based on transaction-level risk
• Optimized frontend architecture, including saved card functionality, dynamic payment buttons, A/B testing with Optimizely, and dynamic error handling
• Compliance-ready, supporting PCI-DSS, secure wallet storage, and adaptive authentication

As with all accesso solutions, accessoPay is designed to evolve; delivering fast, intelligent, and secure checkout experiences that meet the needs of today’s digital-first guests.

About accesso Technology Group plc 

accesso is the leading global provider of patented and award-winning technology solutions that redefine the guest experience, drive increased revenue, streamline operations, and support data-driven business decisions for leisure and entertainment operators. Currently serving over 1,200 venues worldwide, accesso invests heavily in research and development to provide venues with technology that empowers unforgettable guest experiences. Staffed by a team of attractions, cultural venue, and ski industry veterans, accesso partners with venues to maximize guest engagement and revenue through intuitive ticketing, point-of-sale, virtual queuing, distribution, and experience management technologies.

accesso is a public company, listed on AIM: a market operated by the London Stock Exchange. Learn more at accesso.com or follow accesso on X (Twitter), LinkedIn and Facebook.

70 semi-finalists selected from 20,000+ entries will pitch their product ideas live to Daymond John, Lori Greiner, Simu Liu, Stephanie Mehta and Everette Taylor

NEW YORK, Aug. 19, 2025 /PRNewswire/ — Alibaba.com, a leading business-to-business (B2B) e-commerce platform, today announced the celebrity host and judging panel for the U.S. final of its $1 million CoCreate Pitch competition.

Slated to take place during CoCreate 2025 Las Vegas on September 4–5, the U.S. final will be hosted by renowned entrepreneur and Shark Tank icon Daymond John. He will be joined by an all-star panel of judges including:

• Lori Greiner, Star of Shark Tank, Prolific Inventor, Distinguished Entrepreneur & Brand Builder Extraordinaire
• Simu Liu, Actor best known as the first Asian superhero in the Marvel Cinematic Universe; Writer, investor; Chief Content Officer of MiLa;
• Stephanie Mehta, CEO and Chief Content Officer of Mansueto Ventures, publisher of Inc. and Fast Company;
• Everette Taylor, CEO of Kickstarter.

Meet the Host and Judges

Daymond John will serve as the emcee for the U.S. final round of this world’s largest product-focused pitch competition. John is the founder and CEO of the iconic lifestyle brand FUBU, growing the global fashion company into an empire generating over $6 billion in sales. For 17 seasons, he has been a staple of ABC’s multiple Emmy Award-winning Shark Tank where he is also an original Shark. John has been recognized worldwide for advancing economic opportunity and innovation. Beyond television, he leads The Shark Group, helping businesses craft authentic brand strategies and unlock growth, and is a New York Times Best Selling author for multiple books dedicated to financial education.

Lori Greiner, beloved Shark on Shark Tank, holds over 120 U.S. and international patents and has created and marketed over 1,000 products with a 90% success rate on new items launched, making her one of the most prolific inventors of retail and consumer products. Honored with the Sherry Lansing ‘Woman of the Year’ Award and listed as one of Success Magazine’s Top 25 Personal and Professional Development Influencers to Follow. She has earned the nickname “Queen of QVC” for her unmatched success in televised product sales, and will bring her sharp eye for consumer potential and scalability to CoCreate Pitch US Final.

Simu Liu made history as the star of the first Asian-fronted movie in the Marvel Cinematic Universe “Shang-Chi and the Legend of the Ten Rings”.  He is also a rising investor, and the Chief Content Officer of MiLa.  His Homecoming Fund supports Asian-led startups, and he recently appeared as a guest Dragon on Canada’s Dragons’ Den. With over 5 million followers, Simu bridges East and West, culture and commerce.

Stephanie Mehta, CEO and Chief Content Officer of Mansueto Ventures, publisher of Fast Company and Inc., is one of the most respected leaders in business journalism. Mehta previously served as editor-in-chief of Fast Company, and held senior roles at Vanity Fair, Bloomberg Media, Fortune, and The Wall Street Journal. Her work bridges Silicon Valley, Wall Street, and emerging markets, making her a trusted voice among entrepreneurs, investors, and policymakers worldwide.

Everette Taylor is the CEO of Kickstarter, the leading crowdfunding and launch platform for creative projects of all sizes. Under his leadership, the company was named one of TIME’s 100 Most Influential Companies and surpassed $9 billion in pledges to campaigns on the platform. He founded his first company at age 19, was recognized on Forbes 30 Under 30 in 2018, and was also recognized on the TIME100 Next list in 2023. Everette is a widely recognized voice in entrepreneurship, technology, marketing, startups, art, and diversity.

“At Alibaba.com, our mission has always been to make it easy to do business anywhere,” said Liz Wang, Global Head of Commercial Strategy at Alibaba.com. “We’re constantly expanding how we support entrepreneurs—whether through global sourcing, supply chain services, or new innovations like our AI sourcing agent, Accio. Through CoCreate Pitch, we’re proud to back the next generation of founders—not just with funding, but with the tools, expertise, and infrastructure they need to grow and succeed on a global stage.”

A Global Sourcing Ecosystem for Entrepreneurs

The pitch competition is the marquee program of CoCreate 2025, Alibaba.com’s flagship sourcing summit that brings together entrepreneurs, manufacturers, and investors for two days of product innovation and business building.

With over 20,000 applications submitted globally by its the first deadline on August 15, the CoCreate Pitch competition showcases the most innovative product ideas from entrepreneurs across the globe. A total of 100 semifinalists will pitch live—70 in Las Vegas and 30 in London this November—for a shot at winning from a $1 million prize pool, including two grand prizes of $200,000 in cash and Alibaba.com sourcing credits.

Beyond the pitch stage, CoCreate 2025 offers a dynamic platform for entrepreneurs to connect and grow. Over 50 trusted manufacturers from Alibaba.com’s global ecosystem will be on-site, presenting more than 20,000 of the latest product samples from upwards of 200 suppliers. Attendees can also take part in an all-new business matchmaking experience where they’ll engage in targeted 10-minute meetings with key decision-makers to explore samples, discuss customization, and fast-track deals. Complementing these hands-on opportunities, the event will also feature 100+ expert-led workshops addressing the most pressing issues facing today’s small and mid-sized businesses.

Got your ticket to join CoCreate 2025 for the global sourcing revolution and entrepreneurship excitement at: https://registration.eventpack.com/cocreate2025?tracelog=pr0731

Media Contact:

Mike Hong
mike.hong@alibaba-inc.com 

About Alibaba.com

Launched in 1999, Alibaba.com is a leading platform for global business-to-business (B2B) e-commerce that serves buyers and suppliers from over 200 countries and regions around the world. It is engaged in services covering various aspects of commerce, including providing businesses with tools that help them reach a global audience for their products and helping buyers discover products, find suppliers and place orders online fast and efficiently. Alibaba.com is part of Alibaba International Digital Commerce Group.